Orgenesis Inc.
ORGSDelisted May 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001460602
Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Orgenesis Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 18 | 20 | +2 |
| Shares | 2.21M | 2.19M | −24.3K (−1.1%) |
| Value | $1.82M | $1.31M | −$506.0K (−27.8%) |
New holders (4)
Institutions that held Orgenesis Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 16,280 | $9.77K | 0.00% |
| Virtu Financial LLC | 12,112 | $7.00K | 0.00% |
| UBS Group AG | 6,273 | $3.76K | 0.00% |
| Tower Research Capital LLC (TRC) | 631 | $379 | 0.00% |
Sold out (2)
Institutions that held Orgenesis Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Capital Advisors, Ltd. LLC | 852 | $1.00K |
| Wells Fargo & Company | 242 | $199 |